ANASSA announces its collaboration with the ABBOTT company, regarding the supply of rapid test tests for the qualitative detection of the SARS-COV-2 antigen (Ag) in human nasopharyngeal swab samples.
With this collaboration, the two companies pave the way for faster and quality primary health care services related to the control of the Covid-19 pandemic.
The rapid antigen test PANBIO of ABBOTT is a laboratory material that is included in the list of the World Health Organization, which certifies that the said antigen test is recommended by the Organization.
ANASSA continues to continuously invest in new technologies and collaborations with leading companies in the field of health, adjusting its scientific activities, with the main goal of providing substantial solutions to issues concerning the health of the population.